Clinical Trials Logo

Acne Keloid clinical trials

View clinical trials related to Acne Keloid.

Filter by:
  • None
  • Page 1

NCT ID: NCT05608499 Recruiting - Clinical trials for Acne Keloidalis Nuchae

Duobrii Treatment of Acne Keloidalis Nuchae (AKN)

Start date: October 26, 2022
Phase: Phase 3
Study type: Interventional

Acne keloidalis nuchae (AKN) is one of the chronic forms of scarring folliculitis, affecting predominantly the occipital scalp, seen mostly in men of African descent. Duobrii has the advantage of being the only high potency topical steroid-retinoid combination approved by the FDA with dermatologic indication. Researchers are proposing the off-labeled use of Duobrii for the management of early-mild AKN. The research team hypothesizes that subjects will experience significant clinical improvement in lesion counts. Patients will be followed with visits scheduled at baseline, 4 weeks, 8 weeks, and 12 weeks. During these in-clinic visits, there will be surveys regarding the severity of AKN symptoms, photographs, and clinical assessments.

NCT ID: NCT04214483 Recruiting - Acne Vulgaris Clinical Trials

A Pilot Study to Explore the Role of Gut Flora in Acne

Start date: March 2, 2020
Phase:
Study type: Observational

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.

NCT ID: NCT02372786 Completed - Clinical trials for Acne Keloidalis Nuchae

7% Lidocaine/7% Tetracaine Cream Versus 2,5% Lidocaine / 2,5% Prilocaine Cream

OPTICA
Start date: November 2014
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the efficacy of 7% lidocaine / 7% tetracaine cream and 2,5% lidocaine / 2,5% prilocaine cream in reducing self-reported pain during a single laser procedure in the treatment of acne keloidalis nuchae and tattoo removal.

NCT ID: NCT01548898 Completed - Clinical trials for Acne Keloidalis Nuchae

The Efficacy of Laser Assisted Hair Removal in the Treatment of Acne Keloidalis Nuchae; a Pilot Study

Start date: January 2008
Phase: Phase 4
Study type: Interventional

Laser causes elimination and miniaturization of hair shafts that are the principal contributor to inflammation in Acne Keloidalis Nuchae (AKN).

NCT ID: NCT01328080 Completed - Clinical trials for Acne Keloidalis Nuchae

Treatment of Acne Keloidalis Nuchae (Razor Bumps Behind the Neck) Using UV Light Therapy

Start date: February 2011
Phase: N/A
Study type: Interventional

This study is being done to evaluate the effect of targeted UV-B (a component of sunlight) on the treatment of acne keloidalis nuchae (AKN, or razor bumps on the back of the neck). The investigators believe targeted UV-B is a safe and effective way to reduce the appearance of AKN.

NCT ID: NCT00757315 Active, not recruiting - Clinical trials for Acne Keloidalis Nuchae

NdYag Laser for Acne Keloidalis Nuchae

Start date: September 2008
Phase: N/A
Study type: Interventional

Acne Keloidalis Nuchae (AKN) is a long standing hair follicle disease with bumps and scars on the skin of the back of the head and neck. The purpose of this new study is to determine how well a hair removal laser (NdYag Laser) works in treating AKN.

NCT ID: NCT00476697 Terminated - Scleroderma Clinical Trials

UVA1 Light for Scleroderma and Similar Conditions

Start date: January 1997
Phase: N/A
Study type: Interventional

The purpose of this investigation is to evaluate the effectiveness of high-dose UVA1 irradiation in the treatment of fibrosing conditions of the skin, e.g., keloid (a thick scar from growth of fibrous tissue), scleroderma (deposits of fibrous tissue in the skin) and acne keloidalis nuchae (keloids on the back of the neck or hairline) old burn scars, granuloma annulare or other similar skin conditions. This UVA1 dosing schedule has been used successfully in Germany for various skin diseases, such as the above mentioned scleroderma.

NCT ID: NCT00129428 Completed - Keloid Clinical Trials

Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix

Start date: August 2002
Phase: Phase 1/Phase 2
Study type: Interventional

This research study will evaluate the effectiveness of high dose UVB light therapy in the treatment of keloid (or hypertrophic scar), scleroderma, acne keloidalis nuchae, old burn scars, granuloma annulare or related conditions.